CHAMPS clinical trial

From Aaushi
Jump to navigation Jump to search

Introduction

A clinical trial finding that betaseron (interferon-beta 1b) reduced the conversion from early possible multiple sclerosis (MS) to definite MS.

More general terms

Additional terms

References

  1. Journal Watch 21(13):103, 2001 Comi et al Lancet 357:1576, 2001 Ebers Lancet 357:15747, 2001
  2. Journal Watch 20(11):169, 2000 N Engl J Med 342:898, 2000